Disclosure: Some links on this page are affiliate links. If you purchase through these links, we may earn a commission at no extra cost to you.

Find My GLP-1 Path

MERITAIN HEALTH · ZEPBOUND COVERAGE GUIDELast verified

Does Meritain Cover Zepbound? Your Plan, the Oct. 1 Caremark Change, and Real Costs

Does Meritain cover Zepbound? Some employer plans do; others don’t. Meritain administers the benefits your employer selects. CVS Caremark has announced an October 1, 2026 Zepbound addition to its commercial template drug lists—not automatic coverage for every Meritain member. Check your plan, prescribed use, and exact device before paying. Meritain · CVS Health

Meritain Health · Zepbound coverage guide · 2026

Disclosure: Some links on this page are affiliate links, marked (sponsored). If you use one, we may earn a commission at no cost to you. You never need a paid service to follow this guide. How we make money

Jump to your situation

Jump to your situation
If this sounds like you…Start here
"I just got a Zepbound prescription."How to check your Meritain plan
"CVS switched me to Wegovy in 2025."What changes on October 1
"The pharmacy rejected it."Why Zepbound was denied
"It's covered, but the price is huge."What Zepbound costs with Meritain
"My plan excludes weight-loss drugs."Getting your employer to review coverage

Start my Meritain coverage check ↓

Two details change your next step:

  • The October 1 announcement changes Caremark’s commercial template lists. Your employer’s chosen benefits still decide your coverage.
  • Caremark’s prior-authorization and exception documents cover different situations and do not include the same devices.

Start with one focused phone call. We wrote the script for you below.

Four things to check first:

  1. Which pharmacy company is printed on your card
  2. Which drug list your plan uses, and whether your employer adopts the October 1 change
  3. Whether your employer covers Zepbound for the prescribed use
  4. The exact Zepbound device and any prior-authorization, program, or pharmacy rules

This page is for you if:

  • Your insurance card says Meritain Health.
  • You have a Zepbound prescription, or you're about to get one.
  • You got a rejection, a denial, or a price that made your stomach drop.
  • CVS Caremark switched you from Zepbound to Wegovy in 2025, and you want to know if you can switch back.

Skip this page if:

  • You only have Medicare. Your rules are different. Jump to Medicare.
  • You're checking Wegovy, not Zepbound. Read Does Meritain Cover Wegovy?
  • You want to know if Zepbound is medically right for you. That's a talk with a licensed clinician, not a coverage question.

The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.


Does Meritain cover Zepbound in 2026?

Some Meritain plans cover Zepbound and some don't, because each employer picks its own drug benefits. Here are four coverage situations to sort out:

  • covered with prior authorization
  • not on the list, with Wegovy preferred
  • covered only for certain uses, such as sleep apnea
  • excluded completely

Two people at different companies can both carry a Meritain card and get opposite answers. That isn't a mistake. It's how self-funded plans work. Meritain itself tells employers it can set up GLP-1 coverage for diabetes only or for diabetes plus obesity, with choices ranging from less to highly restrictive.

So the real question isn't just "Does Meritain cover Zepbound?" It's "Which benefit, drug list, and approval rules apply to my prescription?"

The 4 coverage situations to check

The 4 coverage situations to check
What your plan saysWhat it meansYour next step before paying
1. Covered, needs prior authorizationZepbound may be paid for the prescribed use once your plan’s requirements are met.Your prescriber submits the required request. Then check whether you qualify for Lilly’s savings card.
2. "Not covered, Wegovy is preferred"Zepbound is excluded from your applicable drug list or needs a formulary exception.Ask whether your plan adopts the October 1 change. If it uses Caremark’s 6981-A exception policy, your prescriber must document that Wegovy did not work, caused side effects that made it unsuitable, or could not be used for a medical reason.
3. Covered only for some usesYour plan may distinguish weight management from obstructive sleep apnea.Ask about the policy for your actual diagnosis. Diabetes-drug coverage alone is not proof of Zepbound coverage.
4. Weight-loss drugs excludedYour plan excludes that benefit or use. A routine prior authorization does not add a missing benefit.Get the exact exclusion. Check any review rights, compare Lilly’s self-pay options, and ask HR about next year.
Your card lists a different pharmacy companyCaremark’s documents do not establish your benefit.Call the pharmacy number on your card and use the script below.

Sources: Meritain, CVS Health, May 28, 2026, Caremark exception criteria 6981-A, Lilly. Framework by The RX Index.


Who decides: Meritain, Aetna, CVS Caremark, or my employer?

Your employer chooses the benefits. Meritain runs the plan and processes medical claims. The pharmacy benefit manager runs the drug list and authorization process chosen for your plan. An Aetna network name is not proof that an Aetna drug list applies. Meritain’s member resources and pharmacy information explain those roles.

A third-party administrator (TPA) is a company an employer hires to run its health plan. A self-funded plan means the employer pays the claims with its own money. A pharmacy benefit manager (PBM) is the company that runs the prescription side: the drug list (also called a formulary), prior authorizations, and pharmacy claims.

Put simply: your employer is the bank, Meritain is the cashier, and the PBM keeps the drug list. The cashier follows the bank's rules.

Who decides: Meritain, Aetna, CVS Caremark, or my employer?
WhoWhat they doWhat their involvement does not guarantee
Your employerPicks the benefits. Decides whether weight-loss drugs are covered at all.Approval of an individual request; that follows the plan’s review process.
Meritain HealthRuns the plan, processes medical claims, answers member callsOne Zepbound rule for every member
Your PBMRuns the drug list, prior authorizations, quantity limits, and pharmacy claimsPayment for an excluded benefit simply because the drug appears on a public list
AetnaSupplies the doctor network many Meritain plans useThat an Aetna drug list is your plan’s list
Your prescriberWrites the prescription and submits clinical recordsApproval or a change to your plan’s benefits
Eli LillyMakes Zepbound and runs the savings cards and cash pricesInsurance coverage through a savings card

Is Meritain the same as Aetna?

No. Meritain Health calls itself "an independent subsidiary of Aetna and CVS Health." It says it runs benefits for more than 2,400 plan sponsors and 1.5 million members. Members use providers in the Aetna network. But an Aetna drug list is not automatically your drug list.

Does Meritain use CVS Caremark?

Some Meritain plans do. Meritain's own pharmacy program, Meritain Health Pharmacy Solutions, gets its pricing through CVS Health. One employer's 2022 member notice says its prescriptions were previously run by Express Scripts and are now "powered by CVS Caremark." That notice describes one employer’s 2022 change, not a switch made by every Meritain plan.

Still, check your card. Employers can pick their own pharmacy company.

A real Meritain employer, on the record

South Orange & Maplewood Board of Education in New Jersey moved to Meritain on January 1, 2026. Its benefits FAQ says:

  • Prescriptions go through CVS Caremark.
  • GLP-1s stay covered for diabetes and/or weight loss.
  • Wegovy is the preferred drug for weight loss.

That's one employer's rule. It proves weight-loss GLP-1 coverage can exist on a Meritain plan. It does not establish Zepbound coverage for that employer or prove yours has it.

The right GLP-1 provider isn't the same for everyone — it depends on your state, your insurance and formulary, your preferred treatment path, and your budget. Because a general answer can't resolve those for you, use The RX Index's Find My GLP-1 Path tool to compare provider options before you choose. This page stays with FDA-approved Zepbound; your plan must confirm coverage.


What changes for Meritain members on October 1, 2026?

CVS Caremark has announced that Zepbound will return to its commercial template drug lists on October 1, 2026 as an additional preferred option alongside Wegovy. Your employer still decides whether its plan adopts that coverage. A template is a starting drug list, not your personal benefit. CVS’s May 28 announcement preserves plan sponsors’ right to customize.

Here's what happened. On July 1, 2025, Caremark took Zepbound off its most common drug lists and made Wegovy the preferred weight-loss GLP-1. At one employer, Indiana University, Caremark moved existing Zepbound approvals over to Wegovy and asked prescribers for new Wegovy prescriptions.

Then on May 28, 2026, CVS announced the reversal. The same release says plan sponsors that use Caremark's template lists can still customize coverage.

What changes—and which Caremark rulebook applies?

What changes—and which Caremark rulebook applies?
QuestionWhat the published sources establishWhat you still need from your plan
What changes on October 1?CVS announced an added preferred Zepbound option on its commercial template lists.Whether your plan adopts it, which device is included, and the effective date for your group.
When is exception policy 6981-A relevant?It sets a Wegovy-related exception test for the listed exclusion-formulary arrangements. Its stated approval period is 12 months.Whether your request needs that exception and any separate benefit or clinical review.
When is prior-authorization policy 6192-C relevant?It sets clinical criteria and quantity limits. Initial approval is 8 months for weight management or 6 months for OSA; renewals are 12 months.Whether your plan uses this policy and version.
Does 6192-C replace 6981-A on October 1?The announcement does not establish that. Both documents were publicly available when checked.The rulebook that applies to your prescription on the date it will be filled.
What about a custom employer list?Plan sponsors retain the right to customize.Your employer’s actual drug list and exclusions.

Sources: CVS Health, Caremark 6192-C v2, and Caremark 6981-A v5. Comparison by The RX Index, checked September 23, 2026.

If you're reading this before October 1: don't stop or change a medicine to wait for a benefit change. Talk to your prescriber first.

One more question to ask on the phone: some plans add a program requirement. Wyoming’s state employee plan requires participation in its CVS weight-management program for applicable medication coverage. That is a Cigna/CVS arrangement, not a Meritain-wide rule. Ask whether your plan has its own program requirement.

Old notices can send you the wrong way. Howard County schools previously announced a CVS weight-management program, but its current prescription-benefit page says weight-management GLP-1 coverage ended March 31, 2026 and that program would no longer be in place. Diabetes treatment was not affected. That is another employer’s change—not a rule for your Meritain plan.

I was switched to Wegovy in 2025. Can I go back to Zepbound?

Your prescriber can consider it if it fits your care and your plan covers the requested product and use. But don't assume your old Zepbound approval comes back on its own. Ask whether you need a new Zepbound prior authorization.

Caremark’s 6192-C policy includes a useful note for switchers. If your plan uses it, the weight-management criteria refer to your BMI and weight-related conditions from when you started any weight-loss drug therapy. The weight you already lost should not be mistaken for your starting BMI under that policy. Point your prescriber to that note.

Why do people want Zepbound back? In Lilly’s SURMOUNT-5 study, adults without type 2 diabetes on their highest tolerated study dose lost 20.2% of body weight on average over 72 weeks with tirzepatide, compared with 13.7% with semaglutide. The trial compared weekly Zepbound 10 or 15 mg with weekly Wegovy 1.7 or 2.4 mg—not the Wegovy pill or a higher-dose product. It was open-label, meaning participants and researchers knew the treatment assigned. Lilly notes that this design makes the findings less certain. Individual results vary. Whether to switch is a decision for you and your prescriber.


How do I check if my Meritain plan covers Zepbound?

Use the pharmacy number on your Meritain card if one is listed. Otherwise, use the member-services number on the card and ask for prescription benefits. Ask whether Zepbound is covered for your prescribed use, which device is covered, whether your plan adopts the October 1 change, and whether prior authorization is required. Ask for the answer in writing and write down a reference number.

If you've been bouncing between phone lines, you're not alone. One member on an Aetna/Meritain plan wrote on Reddit about "going back and forth between my physician and CVS pharmacy over price excess" (r/Zepbound, 2024). That's one person's experience from 2024. It isn't proof of anyone's coverage today. It's the phone loop we're trying to end for you.

Step 1: Read what you've got

Every clue proves something, but none of them proves everything. Use this table to see what you actually know and what to ask next.

Step 1: Read what you've got
What you foundWhat it provesWhat it doesn't proveAsk next
Your card says MeritainMeritain administers your planWhat your drug benefit covers"Who runs my pharmacy benefit?"
Your card lists CVS CaremarkCaremark is involved in your prescription benefitThat your plan uses an unchanged template list"Which drug list applies to my group, and does it add Zepbound October 1?"
News says "Caremark is adding Zepbound back"Caremark announced a template changeThat your employer adopted the change"On what date is Zepbound covered on my plan?"
An Aetna drug list shows ZepboundThat list's statusYour plan's coverage"Which drug list applies to my group?"
Your portal says "prior authorization required"An authorization requirement is shownThat the benefit covers your use, or that you'll be approved"Is my prescribed use covered, and can you send me the written criteria?"
A coworker got approvedTheir particular request was approvedYour eligibility, price, or prescribed-use coverage"Please check my own member record and prescription."

Step 2: Make the call

Use the number on your card first, even if it lists only one. If you cannot find it, Meritain's general member line is 1-888-324-5789, open 7:00 a.m. to 6:30 p.m. Central. Meritain says that's a general line, so you may be put on hold or transferred.

Copy this script:

"Hi. My health plan is administered by Meritain, and I'm checking coverage for Zepbound. 1. Is Zepbound covered on my plan for [weight management / obstructive sleep apnea], the use documented by my prescriber? 2. Which drug list applies to my group? Does my plan adopt the October 1, 2026 Caremark change? 3. Is the exact device and dose on my prescription covered—single-dose pen, KwikPen, or vial? 4. Is prior authorization required? Can you send me the written criteria? 5. Do I have to join a weight management program first? 6. Which pharmacy must I use, and what would I pay for a 28-day fill at that pharmacy, before and after my deductible? 7. Is the prescribed use excluded anywhere in my plan documents? Can you send me that wording? 8. Can I get a reference number for this call?"

Step 3: Write it down

Save these details:

  • the representative's name, the date, and the reference number
  • the exact device and dose they checked
  • the name and date of any policy they quoted
  • the price they gave you

If the story changes later, this log helps you trace the earlier answer. A phone quote is not a final claim approval. Then ask: "Can you send that to my portal or by mail?"

Want the plan document itself? Ask HR for your Summary Plan Description (SPD), the booklet that explains your plan's benefits and exclusions. For private-employer plans covered by the federal employee-benefits law called ERISA, the U.S. Department of Labor explains how to request a copy from your plan administrator in writing. Search it for "weight," "obesity," and "anti-obesity."

Don't want to make the call yourself?

Ro's free GLP-1 Insurance Coverage Checker does it for you. Ro contacts your plan and emails a personalized report on whether the Zepbound pen is covered and what it may cost. New Ro accounts also get a $50 credit. You don't need a paid membership to run the check.

The one thing it won't do: Ro doesn't check KwikPen coverage right now. If your prescription is for the KwikPen, use the call script above instead. It's free too, and it's the better tool for that device.

Ro does focus on the single-dose pen, though. Both Caremark documents discussed here include that device in their scope. That makes the checker a relevant first step for a pen prescription—not proof that your benefit pays for it. The free check does not submit a treatment request, prescribe medication, or approve a prior authorization. Your report is something you can share with your own prescriber.

Have Ro check my Zepbound pen coverage — free (sponsored) → Free report · no paid membership needed · a coverage report, not an approval


What does Meritain need for Zepbound prior authorization?

Meritain doesn't publish one Zepbound rule for every member. If your plan uses CVS Caremark’s published Zepbound policy 6192-C v2, its initial adult weight-management path needs:

  • a baseline BMI of at least 30, or at least 27 with a weight-related condition
  • at least 6 months in a structured weight-management program before starting the drug

Under that policy, first approval for weight management lasts 8 months. BMI is a measure based on height and weight. Baseline means the starting measurement; this policy uses the start of weight-loss drug therapy, including when you switch medicines.

Prior authorization means your plan wants proof before it pays. Your prescriber sends the proof. The plan checks it against a written rulebook. We read Caremark’s publicly posted 6192-C policy, version 2, alongside its separate exception policy. Here's what it asks for, in plain words.

Caremark's Zepbound rules, translated

Caremark's Zepbound rules, translated
RequirementWeight-management path: 6192-C v2Sleep apnea path: 6192-C v2Exception path: 6981-A v5
Who it's forAdultsAdults with moderate-to-severe obstructive sleep apnea and obesityRequests under the exclusion-formulary arrangements named in this policy
BMI rule for initial approvalBaseline BMI of 30+, or 27+ with at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterolCurrent BMI of 30+No BMI test stated in this exception document; other plan rules can still apply
Other must-havesUsed with a reduced-calorie diet and more activityA sleep study—lab or technically adequate home test—showing an AHI of 15+. Used with a reduced-calorie diet and more activity.Records showing Wegovy did not work, caused side effects that made it unsuitable, or could not be used for a medical reason
6-month program historyA program with diet, activity, behavior change, and follow-up for at least 6 months before starting drug therapyNot required by this document’s OSA criteriaNot stated in this exception document
First approval8 months6 months12 months
RenewalAt least 3 months on a stable maintenance dose, plus at least 5% weight loss from baseline or maintaining that loss; diet and activity continue. Renewal: 12 months.Documented qualifying OSA, decreased symptoms from baseline, and a maintenance dose; diet and activity continue. Renewal: 12 months.No separate renewal test set out here

Sources: Caremark 6192-C, version 2; Caremark 6981-A, version 5. Translation and layout by The RX Index.

AHI (apnea-hypopnea index) is the sleep-study score that counts how many times an hour your breathing stops or gets too shallow.

The 6-month rule nobody warns you about

Six months of documented program history isn't something you can produce overnight. If your plan uses this rule, you want to know now, not after a denial.

Ask your prescriber what your chart already shows. Regular visits where your doctor tracked your diet, activity, and weight may matter. Never invent history. The OSA section of 6192-C does not include the 6-month history rule; ask separately about any program your employer requires.

Some plans are stricter

Rulebooks come in versions. Aetna's published 2026 weight-loss policy for GIP/GLP-1 drugs, policy 6450-C, starts at a baseline BMI of 35 for its adult weight-management path. That is an Aetna policy example, not a confirmed rule for your Meritain plan. That's why the most important words on your call are: "Can you send me the written criteria for my plan?"

How long does prior authorization take?

For ERISA-covered private-employer plans, federal rules generally allow up to 15 calendar days for a standard pre-service claim, such as a required approval before treatment. An allowed extension can add 15 days, with notice; a request for missing records can also affect the deadline.

The clock starts when the request is filed under the plan’s reasonable procedures—not only when it is complete. The Department of Labor explicitly says the plan cannot delay the start by counting only complete claims. It does not start merely because a prescription was written.

Urgent requests generally require a decision as soon as medically needed, within 72 hours. Special missing-information rules can apply: notice within 24 hours, at least 48 hours for you to respond, then a decision within 48 hours after the response or response deadline, whichever comes first. Ask your prescriber whether your situation meets the plan’s urgent-care standard.

Heads-up for your doctor's office: Meritain announced an August 2026 move to Availity for its medical-management prior authorizations. A Zepbound prescription usually goes through your pharmacy benefit manager instead. Ask the pharmacy line where the request should be sent. The Availity notice also says appeals are not supported through that update; follow the denial letter for appeals.

Your doctor checklist

Copy this and send it to your prescriber's office.

Zepbound prior authorization checklist—match these items to your plan’s actual policy

  • Exact product: Zepbound single-dose pen, KwikPen, or the exact vial presentation, plus the dose
  • Prescribed use: weight management or obstructive sleep apnea
  • Baseline weight and BMI, with the date. If switching from another weight-loss drug, include the BMI from when that drug started.
  • Weight-related conditions (for example, high blood pressure, type 2 diabetes, high cholesterol)
  • Record of 6+ months in a diet, activity, and behavior program with follow-up before drug therapy, if the applicable weight-management policy requires it
  • Sleep study with AHI score, date, and test type, plus current BMI (sleep apnea path)
  • Wegovy history, if the plan requires the exception rules: dates, doses, results, side effects, or the reason it can't be used
  • For renewal: starting and current weight, percent change, current dose and time on that dose, or the OSA response records your policy requests
  • The plan's written criteria, attached, so every item is answered

Copy the checklist above and send it to your prescriber’s office with your plan’s written criteria.


Which Zepbound will my Meritain plan cover: pen, KwikPen, or vial?

Caremark’s 6192-C prior-authorization policy includes the single-dose pen and KwikPen. Its 6981-A exception policy includes the single-dose pen but excludes KwikPen from that document’s scope. Neither document establishes what your own Meritain plan covers. Ask about the exact product before your prescription is filled.

There are three device types to tell apart, and plans can treat them differently:

  • Single-dose pen: one pen per weekly shot, four pens per 28 days.
  • KwikPen: one pen holds four weekly doses. You attach a new needle each week.
  • Vial: you draw each dose with a syringe. The current label lists both single-dose and multi-dose vials; the LillyDirect vial prices below are for four single-dose vials, not a multi-dose vial.
Which Zepbound will my Meritain plan cover: pen, KwikPen, or vial?
Source or payment pathSingle-dose penKwikPenVials
Caremark prior-authorization policy 6192-C v2Included. Four pens per 28-day supply or 12 per 84-day supply.Included. One KwikPen per 28-day supply or three per 84-day supply.Excluded from this policy’s scope; document refers readers to LillyDirect.
Caremark exception policy 6981-A v5Included, subject to the exception criteriaExcluded from this policy’s scope; document refers readers to LillyDirect.Excluded from this policy’s scope; document refers readers to LillyDirect.
Ro's free coverage checkerChecks itDoes not currently check itNot included in the checker’s listed products
Lilly offer when you pay outside coverageAs low as $499 per 28-day fill for eligible commercially insured patients without single-dose-pen coverageStarting at $299 / $399 / $449 by dose and offer eligibilityThe same advertised self-pay dose prices for single-dose vials through LillyDirect

Sources: Caremark 6192-C, Caremark 6981-A, Ro, Lilly savings terms.

The current prescribing information lists the presentations. Caremark’s 6192-C uses 21- and 63-day processing windows for 28- and 84-day supplies to allow refill processing; that does not change the weekly prescribed dosing schedule.

Why this matters: "Zepbound is covered" doesn't mean every Zepbound is covered. If your plan covers the pen and your doctor sends a vial, the claim can bounce. Say this on the call: "Please check the exact device and dose on my prescription, not just 'Zepbound.'"

The irony: Lilly’s lowest advertised cash prices cover both KwikPen and single-dose vials, while Employer Connect and Medicare’s GLP-1 Bridge use KwikPen. Yet KwikPen is outside the scope of Caremark’s 6981-A exception policy. So the product your plan pays for and the product with a lower cash offer may be different. Only your prescriber should decide whether to switch. LillyDirect · Employer Connect · CMS


Does Meritain cover Zepbound for sleep apnea?

Zepbound is FDA-approved to treat moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity. Whether your Meritain plan pays for that use depends on your employer's plan language. If your plan applies Caremark’s 6192-C v2 policy, initial OSA approval needs a qualifying sleep study with an AHI of at least 15 and a current BMI of at least 30, with diet and activity changes.

The FDA approved Zepbound for OSA on December 20, 2024. It was the first drug approved for this condition. The approval was based on two studies of 469 adults without type 2 diabetes. The current Zepbound label gives recommended OSA maintenance doses of 10 mg or 15 mg.

Here’s how the OSA section differs from the weight-management section in Caremark 6192-C v2:

  • No 6-month program-history rule in this policy’s OSA section. Its weight-management section has one. A separate employer program may still apply.
  • Current BMI counts for initial OSA approval, not the weight-management baseline test.
  • First approval: 6 months. Renewal needs the documented OSA diagnosis, improved symptoms, and a maintenance dose, with diet and activity changes; it lasts 12 months.

What to ask: "Does my plan cover Zepbound when it's prescribed for obstructive sleep apnea, and what does that policy require?"

A plan that excludes weight-loss drugs may or may not still pay for OSA. It depends on how your plan's exclusion is written, so ask for the exact wording.

One line we won't cross: only use this path if you truly have moderate-to-severe OSA confirmed by a sleep study. Never change or relabel a diagnosis to get coverage. It's wrong, and it puts you and your prescriber at risk. If you snore, feel tired all day, or someone has noticed you stop breathing at night, ask your doctor about a sleep study for its own sake.


How much does Zepbound cost with Meritain?

There's no single Meritain price for Zepbound. If your plan covers the single-dose pen and you qualify for Lilly’s commercial savings card, a 28-day fill can cost as little as $25—but the card saves at most $100 on that fill. Lilly also advertises self-pay KwikPen and single-dose-vial prices starting at $299, $399, or $449 by dose, subject to the offer terms. Lilly’s current terms · LillyDirect

We lined up the payment paths below. They are not a cheapest-to-most-expensive ranking: your plan’s share and any employer contribution change the order.

The Zepbound price ladder for Meritain members

The Zepbound price ladder for Meritain members
PathMedication price or cost basisFine print
1. Plan covers the single-dose pen + Lilly commercial savings cardAs little as $25 for an eligible 28-, 56-, or 84-day fillSavings caps: $100 / $200 / $300, respectively. Maximum $1,300 and 13 fills per calendar year. Card expires Dec. 31, 2026. Government-program beneficiaries are excluded from this commercial card.
2. KwikPen or single-dose-vial self-pay offerStarting at $299 for 2.5 mg, $399 for 5 mg, and $449 for 7.5–15 mgHigher-dose $449 offers have a refill-purchase rule: within 45 days after delivery/receipt of the prior qualifying fill to keep the offer. Without it, regular prices are $499 for 7.5 mg and $699 for 10–15 mg. Supplies, taxes, or fees can add to the bill.
3. Commercial insurance does not cover the single-dose pen + Lilly’s eligible pen offerAs low as $499 per 28-day fillRequires eligible commercial insurance—not just any uninsured or cash-paying patient. Maximum 13 fills per calendar year. Card expires Dec. 31, 2026.
4. Your employer joins Lilly Employer Connect$449 is Lilly’s price to participating network pharmacies for KwikPen at all dosesIt is not your guaranteed price. Your amount depends on the employer contribution, pharmacy price, and program or dispensing fees. See the employer section.
5. No applicable insurance payment or discountGet the pharmacy’s cash quote for your exact device, dose, and days’ supplyA manufacturer list price is not a guaranteed retail bill. Compare the actual quote with the eligible options above before filling.

Sources: Lilly Zepbound savings and full terms, LillyDirect, and Lilly Employer Connect. Public offers checked September 23, 2026; no personal pharmacy claim was priced.

One “month” here means 28 days, not a calendar month. The current KwikPen commercial-not-covered and separate KwikPen Self-Pay cards allow up to 11 fills per calendar year and expire December 31, 2026. Do not apply the single-dose pen’s 13-fill limit to KwikPen. The higher-dose offer applies to the first qualifying purchase; later qualifying purchases must meet the 45-day rule. Full card terms

About the $299 price: 2.5 mg is the starting dose, not an approved maintenance dose. Budget for the dose your prescriber expects you to reach.

Why "covered" can still cost hundreds

The eligible covered-pen card saves up to $100 on a 28-day fill. Here's an example, not a personal quote:

  • Your plan covers the pen, but you haven't met your deductible. Your share is $600.
  • The card takes off $100.
  • You pay $500, not $25.

With that $100 cap, a $25 final price requires the plan’s share to leave you no more than $125 before the card, and the other terms must be met.

Our rule of thumb: covered isn't always cheapest

If your share after the card is more than the KwikPen cash price for your dose, cash may cost less that month.

The trade-offs are real, though:

Run the numbers for your dose. Then decide with your prescriber.

A quick break-even check: add $100 to the applicable self-pay medication price. That gives the pre-card insurance share at which the two medication costs tie, assuming you receive the full $100 covered-pen savings.

Our rule of thumb: covered isn't always cheapest
Self-pay dose and qualifying pricePre-card insurance share that ties itExample of when self-pay costs less for the medication
2.5 mg: $299$399Insurance share of $450 − $100 card = $350, versus $299 self-pay
5 mg: $399$499Insurance share of $550 − $100 card = $450, versus $399 self-pay
7.5–15 mg: $449 with the offer$549Insurance share of $600 − $100 card = $500, versus $449 self-pay

Calculations by The RX Index using Lilly’s published offers, checked September 23, 2026. This compares a covered single-dose pen with a qualifying self-pay product at the same prescribed dose. It excludes supplies, care fees, taxes, and the future value of deductible credit. It assumes savings remain available under the card’s limits. It is a price comparison—not a recommendation to change dose or device.

Two more catches for self-funded plans

  • "Alternate funding programs." Lilly’s terms bar the cards when an insurance arrangement requires pursuing the relevant manufacturer assistance as a condition or prerequisite for Zepbound coverage. That is more specific than merely having a plan that uses an outside vendor. Ask: "Does our arrangement make me ineligible under this card’s alternate-funding terms?" Lilly’s terms
  • HSA and FSA. Qualified out-of-pocket medical costs can be eligible under IRS rules, but check the exact offer. Lilly’s commercial-card terms bar reimbursement of the amount the card saved you. Its separate KwikPen Self-Pay card goes further: its terms bar reimbursement of the purchase through a healthcare reimbursement account. Do not assume every Lilly cash offer permits HSA/FSA reimbursement. Ask Lilly and your benefits administrator about your specific program before paying. Lilly’s full terms

Do I need help getting Zepbound covered, and is Ro worth it?

You don't need to buy a telehealth membership to check your Zepbound coverage. Start with the pharmacy number on your card. Your current prescriber may help too, though visits or administrative work can have charges. Paid help makes sense if you need a new prescriber or want a program that handles the paperwork. For this page, our editorial pick for that situation is Ro: its public pages offer FDA-approved Zepbound, a free single-dose-pen coverage check, and KwikPen cash prices that match the Lilly offers shown here. Ro checker · Ro pricing

First, the safety basics

Zepbound is a prescription drug with a boxed warning: it caused thyroid C-cell tumors in rats, and it's unknown whether it does in humans.

Don't use Zepbound if:

  • you or your family have a history of medullary thyroid cancer
  • you have Multiple Endocrine Neoplasia syndrome type 2
  • you've had a serious allergic reaction to tirzepatide or any ingredient in Zepbound

Common side effects include nausea, diarrhea, vomiting, constipation, and stomach pain.

Coverage says nothing about whether a drug is right for your body. A licensed clinician should make that call with you.

The current label also warns about severe stomach problems, dehydration-related kidney injury, gallbladder problems, and pancreatitis. Do not combine Zepbound with another tirzepatide product or a GLP-1 drug. Tell your clinician about diabetes medicines and any planned anesthesia. Stop Zepbound and contact your prescriber if pregnancy occurs; oral birth-control users need a non-oral method or added barrier protection for 4 weeks after starting and after each dose increase. This is a safety summary, not the full label.

Your options, side by side

Your options, side by side
QuestionYour own prescriberRoCheck directly with your plan
Cost to check coverageAsk the office about any visit or paperwork feeFree checker; paid care is separateNo paid telehealth membership needed
Files prior authorizationAsk whether the office will submit itRo says its insurance concierge handles paperwork for membersYou can obtain the requirements; clinical records may need your prescriber
Checks KwikPen insurance coverageCan ask the plan about the exact prescriptionThe free checker does not currently support KwikPenUse our call script
Cash KwikPen priceYour pharmacy or LillyDirect$299 / $399 / $449 advertised by dose and offer eligibility, plus membershipLillyDirect’s advertised medication prices; a prescription is still required
Care or membership feeOffice visit costs and any other charges$39 first month; then $149 monthly or as low as $74/month equivalent with annual prepaymentNone for this checklist; medical care is separate

What we confirmed about Ro (checked September 23, 2026)

We checked Ro’s public pages against Lilly’s posted dose prices. We did not enroll, request a coverage report, or test its care or support.

What we confirmed about Ro (checked September 23, 2026)
ItemProvider-statedWhat our public-source check confirms—and what it does not
Free coverage checkerChecks the Ozempic, Wegovy, and Zepbound pens; advertises a $50 credit for new Ro accountsRo’s checker page lists those products. It does not currently check Zepbound KwikPen, Foundayo pill, or Wegovy pill. We did not test a member’s result.
Membership$39 for the first month; refunded if not eligible for GLP-1sRo pricing states this introductory offer. It is not a promise of a refund simply because insurance denies the drug.
Ongoing membership$149 monthly, or as low as $74/month with the annual plan paid up frontThe published price separates medication from membership. The $74 is a monthly equivalent, not a month-to-month payment option.
KwikPen cash price$299 for 2.5 mg, $399 for 5 mg, and $449 for 7.5–15 mg with the offerThese advertised medication amounts match LillyDirect’s posted dose prices. This is not a checkout test or proof that every extra fee is identical.
Insurance helpInsurance-concierge and prior-authorization support for membersRo lists the service; your plan still decides the request. A new prescriber is not a new insurance benefit.
Renewal and cancellationMembership renews automatically at the agreed price and frequencyRo’s terms require cancellation at least 48 hours before renewal to avoid the next charge. Paid membership fees are generally non-refundable, apart from an applicable stated offer. Charges continue even when you do not receive medication, until you cancel. Cancel through the account or contact Ro.

Keep the two bills separate: a qualifying $449 medication fill plus one $149 monthly membership charge is $598, before supplies or other fees. That is an example of two charges—not a calendar-month guarantee, since the medication supply is 28 days.

Who should skip Ro: if your plan covers Zepbound and your own doctor will file the paperwork, check Lilly's savings card eligibility and keep your money. We earn nothing on that path. It's still the right one for you.

Who Ro fits: you don't have a prescriber who will manage Zepbound, you want someone else to deal with the insurance side, or your plan won't pay and you want the KwikPen at Lilly's cash price with ongoing care.

Does that sound like your situation? See Ro's Zepbound prices and check eligibility (sponsored) → Get started for $39, then as low as $74/month with annual plan paid upfront. Medication billed separately. $39 refunded if you're not eligible.

Why there are no compounded drugs here: you searched for Zepbound, an FDA-approved medicine made by Eli Lilly. Compounded tirzepatide is not Zepbound and is not FDA-approved. The FDA doesn't review compounded drugs for safety, effectiveness, or quality before they're sold. Paying cash for a compounded drug does not make Zepbound a covered benefit. It's a different decision, so it doesn't belong on this page.


Why was Zepbound denied on my Meritain plan?

First, find out which kind of "no" you got:

  • missing paperwork
  • a Wegovy-first rule
  • the wrong device
  • a program requirement
  • a true benefit exclusion

A missing record or product mismatch calls for a different response than a benefit exclusion. An appeal can challenge a wrong decision, but it does not automatically add a benefit your plan excludes.

Get the exact rejection wording in writing. Then find it below. These are example messages, not a diagnosis of your claim from the wording alone.

Why was Zepbound denied on my Meritain plan?
What you were toldWhat it can meanYour next move
"Prior authorization required"An authorization gate; not itself a final clinical denialConfirm whether a request exists, obtain the written criteria, and have the prescriber submit to the correct place.
"Not on formulary" / "Wegovy is preferred"Your applicable drug list leaves Zepbound off or requires an exceptionAsk about your plan’s October 1 decision and its exception process. Use documented Wegovy history when required.
"Criteria not met"A record is missing or you do not meet a requirementAsk which criterion failed. Correct missing facts or appeal a wrong decision; do not invent history.
"Plan exclusion" / "not a covered benefit"A drug, benefit, or prescribed use is excludedRequest the exact plan provision and any review rights. Then compare cash options and ask HR about future benefits.
"Product not covered"Could be a device, drug-list, or benefit restrictionHave the pharmacist check the exact product billed and ask the plan which presentation, if any, is covered.
"Must enroll in a program"Your plan requires a programConfirm which program, whether your prescribed use is subject to it, and when coverage can begin after enrollment.
"Quantity limit" / "Refill too soon"An amount or timing editAsk the pharmacy to check the quantity, days’ supply, next fill date, and any available override.
"Covered, but you owe $___"Deductible or other cost sharing rather than a denialSee the price ladder and break-even check.

For more pharmacy rejection messages, see our guide to GLP-1 pharmacy claim rejection codes.

How appeals work on a Meritain plan

Meritain's general member page describes three levels:

  1. First appeal: within 180 days of the denial notice
  2. Second appeal: within 60 days of the first-level decision
  3. External review: independent review for eligible cases, generally after internal appeals or when another exception permits it

For ERISA-covered private-employer plans, the Department of Labor says:

  • You get at least 180 days to appeal.
  • A new reviewer must look at your case.
  • An appeal of a request made before care must be decided within 30 days (15 days per level if there are two).
  • You can ask for free copies of the documents used in the decision.

Government plans, like a public school district's plan, and most church plans are not covered by these ERISA rules. External review is not available for every kind of denial. Use the rights, deadlines, and recipient in your own notice.

Send your appeal to whoever your denial letter names. For a pharmacy denial, that may be your PBM, not Meritain.

Track 1: something was missing. Fix the gap and ask if a new request is faster than an appeal. Do not let a resubmission or phone call run out your appeal deadline.

Track 2: you disagree with the decision. File the appeal with records that answer the exact rule you failed.

Track 3: flat exclusion. Ask whether the exclusion was applied correctly to your drug and prescribed use. A medical-necessity letter alone does not add an excluded benefit. Ask HR about next year and compare cash prices.

Free appeal letter

Subject: Appeal of Zepbound denial — [Your name], Member ID [#], Request/Claim # [#] I am appealing the denial dated [date] for Zepbound [exact device and dose], prescribed by [prescriber name] for [weight management / obstructive sleep apnea]. The denial says: "[copy the exact reason]." My request meets my plan's written criteria:

  • [Criterion 1]: [how you meet it] — see attached [record]
  • [Criterion 2]: [how you meet it] — see attached [record]

Attached: [denial letter, prescriber letter, records]. Please review this appeal under my plan's written criteria. Please send me free copies of any criteria, guidelines, or records used in this decision. [Your name, phone, email]

Only include facts your records support.

Copy the letter above, add only supported facts, and send it to the address or portal named in your denial notice before the deadline.


Can I get my employer to cover Zepbound next year?

Yes, you can ask, and the best time is before your employer sets next year's benefits. Your self-funded employer can review adding weight-loss drug coverage or using a program such as Lilly Employer Connect. Employer Connect’s $449 is Lilly’s price to participating network pharmacies for KwikPen at all doses—not a guaranteed amount the employee pays. Lilly’s launch terms say employer contributions and program or dispensing fees affect the final cost.

You're not asking for something unusual. In 2024, 44% of employers with 500+ workers covered weight-loss drugs, and 64% of employers with 20,000+ workers did. Lilly says about half of employees with commercial coverage still lack covered access to obesity medicines.

In Lilly’s March 5, 2026 launch announcement, Ilya Yuffa put it plainly: starting treatment is often "an access decision driven by coverage and cost."

What Lilly Employer Connect is

Lilly Employer Connect launched March 5, 2026. Here's how it works:

  • Lilly offers the Zepbound KwikPen to participating network pharmacies at $449 for all doses.
  • The employer chooses how much to contribute. Your price also depends on the pharmacy and program or dispensing fees.
  • It launched with more than 15 independent program administrators, including GoodRx, Mark Cuban Cost Plus Drug Company, Sesame, Teladoc Health, and Transcarent.
  • Lilly's employer contact is [email protected].

It works outside the normal drug list. That makes it a real option for an employer that doesn't want to change its whole pharmacy plan.

Free HR request letter

Subject: Request to review Zepbound coverage for next plan year Hi [HR/Benefits name], I'm on our Meritain-administered health plan. I'd like to ask the benefits team to review coverage for FDA-approved weight-management medicines like Zepbound before next plan year. Two options may help control cost: 1. CVS Caremark announced an October 1, 2026 addition of Zepbound as a preferred option on its commercial template drug lists. If our plan uses Caremark, could we review whether our plan adopts that change? 2. Lilly Employer Connect offers a separate option for employer-supported access. Its $449 KwikPen price is to participating network pharmacies, not the final employee price. Could we compare the full pharmacy and program cost, then any employer contribution? Lilly’s employer contact is [email protected]. Could you tell me when next year's plan decisions are made and how employees can share feedback? Thank you, [Your name]

Copy the letter above and send it to your HR or benefits team before next year’s benefit decisions are made.


What if I have diabetes, change plans, or use Medicare?

A few situations change the Zepbound answer on a Meritain plan:

  • type 2 diabetes
  • a new employer plan
  • COBRA
  • Medicare
  • a teenage dependent
  • a switch from compounded tirzepatide

Find yours below.

I have type 2 diabetes

Zepbound is not FDA-approved to treat type 2 diabetes. Mounjaro is Lilly’s tirzepatide product approved for type 2 diabetes. Having diabetes does not, by itself, rule out Zepbound for its approved weight-management use. Type 2 diabetes also counts as a weight-related condition on Caremark's Zepbound weight path. Ask your prescriber which drug and which coverage path fits you. See what GLP-1s CVS Caremark covers.

My employer just switched to Meritain

Don't assume an old approval carries over. South Orange & Maplewood told staff that prior authorizations from its old plan would not carry over to Meritain. Check your refill date and start the new request early.

I'm leaving my job or starting COBRA

COBRA continuation coverage must match the coverage available to similarly situated active participants. It does not freeze old Zepbound benefits: changes affecting those active participants also apply to COBRA coverage. A new employer means new plan documents. Check before your first refill there.

I'm turning 65 or I'm on Medicare

Lilly’s commercial-insurance savings card excludes Medicare and other government-program beneficiaries. Its separate cash-pay options have different terms and operate outside insurance. Do not use a commercial card for a Medicare claim. Lilly’s terms

The Medicare GLP-1 Bridge runs from July 1, 2026 through December 31, 2027. Eligible Part D members meeting its clinical rules pay $50 per monthly supply. For Zepbound, it includes KwikPen only, not single-dose pens or vials.

The Bridge is not the path for someone with moderate-to-severe OSA, type 2 diabetes, or MASH liver disease with moderate-to-advanced scarring but no cirrhosis. CMS directs those patients to regular Part D, even if their plan denies coverage. In 2026, a prior GLP-1 fill covered through Part D that year also blocks Bridge eligibility. Check Medicare’s eligibility questions or our Medicare GLP-1 Bridge eligibility guide.

Can my teenager get Zepbound through my plan?

The current Zepbound label says safety and effectiveness have not been established in pediatric patients. Caremark's criteria are written for adults, and Lilly's savings card requires age 18+. Talk with your child's clinician.

I'm on compounded tirzepatide and want brand Zepbound

Compounded tirzepatide isn't Zepbound, so a past compounded prescription isn't a Zepbound approval. Start fresh with the call script, and bring your full medication history to your prescriber.


What are the quick answers about Meritain and Zepbound?

Is Meritain the same as Aetna? No. Meritain Health is an independent subsidiary of Aetna and CVS Health that runs self-funded plans for employers. Many Meritain plans use the Aetna doctor network, but Aetna drug lists don't automatically apply to your plan.

Does Meritain use CVS Caremark? Some plans do. Meritain's own pharmacy program has a CVS Health relationship, and employer documents show Meritain plans using CVS Caremark. Your employer can choose another pharmacy company, so check the pharmacy side of your card.

Is CVS Caremark covering Zepbound again? CVS has announced an October 1, 2026 addition to its commercial template lists as a preferred option alongside Wegovy. Your employer’s adoption and benefit rules still matter. CVS announcement

Does Meritain cover Zepbound for weight loss? Your plan must cover the prescribed weight-management use, and the exact product must meet its drug-list, authorization, and pharmacy rules. A weight-loss benefit alone does not establish Zepbound coverage. Meritain

Does Meritain cover the Zepbound KwikPen? Ask by name. Caremark’s 6192-C policy includes KwikPen, while 6981-A excludes it from that document’s scope. Neither proves your plan’s benefit. Lilly’s self-pay prices start at $299, $399, or $449 by dose and offer eligibility; higher-dose regular prices can reach $699. See the device comparison.

What BMI do I need for Zepbound on a Caremark plan? Under Caremark 6192-C v2, initial weight-management approval uses baseline BMI of at least 30, or at least 27 with a weight-related condition. Initial OSA approval uses current BMI of at least 30 plus the sleep-study criteria. Other policies differ; the Aetna example above uses baseline BMI of at least 35 for adult weight management. Get your own policy.

How long does a Zepbound approval last? Under Caremark 6192-C v2, first approval is 8 months for weight management or 6 months for OSA. Renewals are 12 months. Those periods are not universal Meritain rules. Use the expiry date on your approval.

How long does prior authorization take? For ERISA-covered plans, a standard pre-service request generally has a 15-calendar-day deadline, with specific extension rules. Urgent requests generally have a 72-hour limit, with special missing-information rules. The clock starts with a properly filed request—not only a complete one. See the timing explanation.

How much is Zepbound with Meritain? Your plan and pharmacy must quote your cost. An eligible covered single-dose-pen fill can be as little as $25, with a $100 savings cap per 28 days. Self-pay KwikPen and single-dose-vial offers start at $299, $399, or $449 by dose; the higher-dose offer and extra costs have conditions. See the price table.

Can I use the Zepbound savings card with a Meritain plan? An eligible commercially insured member may qualify, but a Meritain card alone does not settle it. Check the exact Lilly program, prescribed product and use, age and residency rules, government coverage, and alternate-funding restrictions. The cards described here expire December 31, 2026. Lilly’s eligibility terms

Does paying cash count toward my deductible? Not under Lilly's self-pay terms. Cash purchases can't be billed to insurance or counted toward your deductible.

Can I use my HSA or FSA for Zepbound? Check both the account rules and your exact Lilly offer. You cannot claim the amount a commercial savings card covered. The separate KwikPen Self-Pay card also bars purchase reimbursement through a healthcare reimbursement account. See the HSA/FSA explanation above before paying.

What is Lilly Employer Connect? A program launched March 5, 2026 for employer-supported access. Lilly’s $449 all-dose KwikPen price is to participating network pharmacies. The employee price depends on contributions and pharmacy or program fees. Lilly’s announcement

What's Meritain's phone number? Use the number on your card first. Meritain's general member line is 1-888-324-5789, open 7:00 a.m. to 6:30 p.m. Central.

Does Meritain cover Wegovy? It also depends on your employer. See our full guide: Does Meritain Cover Wegovy?


What did we verify, and what can only your plan answer?

We checked the public coverage documents, manufacturer offers, and provider terms linked here on September 23, 2026. We did not log into any plan, call Meritain or Caremark, submit a claim, enroll in Ro, or confirm anyone's approval. Your plan-specific documents and claim decision—not this public-source guide—establish your benefit. The Reddit account is an attributed personal experience, not coverage evidence.

What we actually verified

What we actually verified
What we checkedSourceWhat it establishesWhat it does not establish
Meritain’s role, member line, hours, and general appeal informationMeritain FAQ and member pageThe administrator’s published role, contacts, and general processYour pharmacy benefit or every appeal right for your claim
Employer choice over GLP-1 benefit designMeritainDifferent benefit designs are availableWhich design your employer chose
A Meritain–Caremark pharmacy arrangementMeritain pharmacy page and Ketchikan’s 2022 noticeA corporate relationship and one dated employer exampleThat every Meritain plan uses Caremark
One employer’s 2026 transition and GLP-1 statementsSouth Orange & Maplewood FAQThat FAQ names Meritain, Caremark, weight-loss coverage, and preferred WegovyZepbound coverage or another employer’s benefits
Announced October 1 formulary changeCVS HealthThe announced template change and sponsor discretionAutomatic adoption by your plan
Two different Zepbound policy documents6192-C v2 and 6981-A v5Published criteria, device scope, and approval durationsAn October 1 policy handoff or your plan’s chosen version
Different employer program decisionsWyoming and HCPSSOne program requirement and one later withdrawal of coverageA rule for Meritain members generally
Approved uses, devices, and safetyFDA OSA announcement and current labelFDA-approved uses and prescribing informationWhether treatment suits you or your plan pays
Savings limits and self-pay pricesLilly terms and LillyDirectAdvertised offers, their limits, and product distinctionsYour final pharmacy bill
Employer ConnectLilly launchPharmacy acquisition price and program structureYour employer’s participation or employee price
Claim and appeal proceduresDepartment of Labor claims guide and timing FAQERISA claims-process requirements within their scopeA universal deadline for every public-employer or other non-ERISA plan
Medicare’s separate BridgeCMSProduct scope and eligibility limitsYour personal eligibility
Ro’s checker, prices, and cancellation termsRo checker, pricing, and termsWhat Ro publicly states, with the listed Zepbound prices cross-checked against LillyA tested coverage report, care experience, or personal price

What we couldn't verify from the open web: your employer's pharmacy company, your drug list, whether your plan adopts the October 1 change, your deductible, your copay, or whether you'll be approved.

Who wrote this and why: The RX Index Research Team. We read Caremark's Zepbound rulebooks line by line, pulled Meritain's own pages and a real Meritain employer's benefits FAQ, and checked Lilly's current terms. We did it because a page that treats Meritain like one national insurance policy gives you the wrong answer from the first sentence. Found an error? Our corrections policy explains how we fix it, with a dated note. See our methodology.

The decision tables, call script, letters, and break-even calculations are our assembled tools. The underlying policy and price facts come from the linked sources. They are not a private database of member benefits or a guarantee of approval.


What should I do in the next 10 minutes?

Get the card, the exact prescription, and the right questions in front of you. You can start now; a final plan answer may take more than one call.

  • [ ] Grab your insurance card and read both sides.
  • [ ] Find the pharmacy number or pharmacy company name.
  • [ ] Check the exact Zepbound device and dose on your prescription.
  • [ ] Call and read the script above.
  • [ ] Ask whether your plan adopts the October 1, 2026 Zepbound change.
  • [ ] Get the written criteria and a reference number.
  • [ ] Send the doctor checklist to your prescriber.
  • [ ] If the answer is no, match it to the denial table and pick your path.

Still not sure which GLP-1 program is right for you? Take our free matching quiz — it takes about 2 minutes.


Related guides: Does Meritain Cover Wegovy? · What GLP-1s CVS Caremark covers · Zepbound providers that accept insurance · How to get insurance to cover a GLP-1 · GLP-1 benefits verification explained · Medicare GLP-1 Bridge eligibility · Find My GLP-1 Path

Content is for informational purposes only and is not medical advice. Talk with a licensed clinician before making treatment decisions.

Your situation changes the answer

Find My GLP-1 Path

The right GLP-1 provider isn't the same for everyone. It depends on your state, your insurance and formulary, whether you want an FDA-approved or compounded medication, your preferred route (injection or oral), and your budget. Because a general answer can't resolve those for you, use The RX Index's Find My GLP-1 Path tool to get a personalized provider match with source-verified pricing before you choose.

  • What it asks: your state, insurance situation, medication preference, budget, and support needs
  • What you get: a personalized shortlist of GLP-1 providers matched to your situation, with verified pricing and the right questions to ask
  • Cost: free · about 2 minutes · no signup
Find My GLP-1 Path